Effect of Prenatal Zidovudine on Disease Progression in Perinatally HIV-1–Infected Infants
Authors:
- Orlando Gómez-MarínOGOrlando Gómez-Marín
- Gwendolyn B. ScottGSGwendolyn B. Scott
- Silvia GuastiSGSilvia Guasti
- Mary Jo O'SUllivanMOMary Jo O'SUllivan
- Ricardo Hugo OliveiraRORicardo Hugo Oliveira
- Charles D. MitchellCMCharles D. Mitchell
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (2) , 154-161
Abstract
To determine the influence of prenatal zidovudine (ZDV) prophylaxis on the course of HIV- 1 infection in children by comparing the clinical outcome of infants born to HIV- 1-seropositive mothers who did versus those who did not receive ZDV during pregnancy. Medical records of HIV-1-seropositive mothers and their infants were reviewed retrospectively. Participants were divided according to maternal ZDV use: no ZDV (n = 152); ZDV (n = 139). The main outcome measure was rapid disease progression (RPD) in the infant, defined as occurrence of a category C disease or AIDS-related death before 18 months of age. HIV vertical transmission rates were significantly different (no ZDV versus ZDV: 22.3% versus 12.2%; p = .034). Among infected infants, the RPD rate was 29.4% in the no ZDV group compared with 70.6% in the ZDV group (p = .012), and prematurity was significantly associated with a higher risk of RPD (p = .027). The rate of RPD was significantly higher among perinatally infected infants born to HIV-infected mothers treated with ZDV than among infected infants born to untreated mothers. The decreased proportion of infected infants with nonrapid disease progression in the former group might be related to the ability of ZDV to block intrapartum transmission preferentially and also to nonrapid disease progression resulting from intrapartum transmission.Keywords
This publication has 33 references indexed in Scilit:
- Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease ProgressionThe Journal of Infectious Diseases, 1999
- Effect of maternal CD4 + cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infectionThe Journal of Pediatrics, 1997
- Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group1996
- Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1The Journal of Pediatrics, 1995
- Rapid Increases In Load Of Human Immunodeficiency Virus Correlate With Early Disease Progression and Loss of CD4 Cells in Vertically Infected InfantsThe Journal of Infectious Diseases, 1994
- Relation of the Course of HIV Infection in Children to the Severity of the Disease in Their Mothers at DeliveryNew England Journal of Medicine, 1994
- Estimating the incubation period of paediatric AIDS in RwandaAIDS, 1992
- Longitudinal Study of 94 Symptomatic Infants With Perinatally Acquired Human Immunodeficiency Virus InfectionAmerican Journal of Diseases of Children, 1990
- Survival in Children with Perinatally Acquired Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1989
- Incubation periods for paediatric AIDS patientsNature, 1988